Edition:
United Kingdom

bluebird bio Inc (BLUE.OQ)

BLUE.OQ on NASDAQ Stock Exchange Global Select Market

137.06USD
18 Apr 2019
Change (% chg)

$-2.33 (-1.67%)
Prev Close
$139.39
Open
$141.00
Day's High
$142.33
Day's Low
$133.16
Volume
339,957
Avg. Vol
193,896
52-wk High
$199.35
52-wk Low
$87.64

Select another date:

Fri, Mar 29 2019

EMA panel recommends approval of Bluebird Bio's first gene therapy

A European Medicines Agency panel on Friday recommended a conditional marketing approval for a gene therapy from Bluebird Bio Inc as a genetic blood disorder treatment, setting the stage for the U.S. biotech to win its first regulatory nod.

UPDATE 1-EMA panel recommends approval of Bluebird Bio's first gene therapy

March 29 A European Medicines Agency panel on Friday recommended a conditional marketing approval for a gene therapy from Bluebird Bio Inc as a genetic blood disorder treatment, setting the stage for the U.S. biotech to win its first regulatory nod.

EMA panel recommends approval of Bluebird Bio's first gene therapy

March 29 A European Medicines Agency panel on Friday recommended a conditional marketing approval for a gene therapy from Bluebird Bio Inc as a genetic blood disorder treatment, setting the stage for the U.S. biotech to win its first regulatory nod.

Select another date: